| Deal | Days Silent | | AbbVie - Rinvoq | 20d |
| AbbVie - Vraylar | 20d |
| ACADIA Pharmaceuticals | Daybue | Rett syndrome | 20d |
| Alexion Pharmaceuticals - Ultomiris | 20d |
| Alkermes - Libalvi | 20d |
| Alnylam Pharmaceuticals | Amvuttra | ATTR-CM | 20d |
| Amgen Ultrarare US -Actimmune (CGD) | 20d |
| argenx US Vyvgart gMG | 20d |
| AstraZeneca | aHUS, PNH, HPP | UAE - Phase 2 | 20d |
| AstraZeneca | ATTR-CM | UAE - Phase 2 | 20d |
| AstraZeneca | PNH | UAE | 20d |
| Bayer | ATTR-CM | DE | 20d |
| Biogen - leqembi | 20d |
| Biogen US | 20d |
| BMS - US | 20d |
| BMS Breyanzi Patient Finder | 20d |
| BMS Portfolio Exploration Digital Health Team Patient Finder | 20d |
| Centene Patient Finder | 20d |
| Clinical University Childrens Hospital, Latvia (BUKS) | 17d |
| Eli Lilly and Company | 20d |
| EMD Serono | MS & Rare Disease | US | 20d |
| Genentach | Ocrevus | 20d |
| Genentech - Esbriet | 20d |
| Genentech - Xolair | 20d |
| Glenmark Pharma | 19d |
| GNAL | 14d |
| GoodApple - Menopause RFP | 20d |
| HCF Hospitals Contribution Fund | 20d |
| Ipsen - Sohonos | 20d |
| J&J Immunology (Stelara) US - Phase 1 | 20d |
| J&J Immunology (Tremfya) US - Phase 1 | 20d |
| Jazz Pharma | 20d |
| Jazz Pharmaceuticals US- Xywav | 20d |
| Novartis - Cosentyx (E2E Care Journey) | 20d |
| Novartis Fabhalta Patient Finder | 20d |
| Novartis Kesimpta Patient Finder | 20d |
| Ontario Enhancement - Gender Neutrality | 16d |
| Ontario Enhancement - Health811 Post Login Experience | 16d |
| Ontario Enhancements | 16d |
| Ontario SOW 9 Enhancement - OHT Mapping - Planning Only | 16d |
| Ontario SOW10 Enhancement Opportunity - Condition Library - Planning and Development | 16d |
| Ontario SOW9 Enhancement - Trusted User (Deferred Auth) - Planning Only | 16d |
| Pfizer | ATTR-CM | DE | 20d |
| Progyny | Endometriosis | US | 20d |
| Roche - Piasky | 20d |
| Roche LatAm | 20d |
| Roche | Neurology & Oncology | Global | 20d |
| Roche - Evrysdi | 20d |
| Takeda - Alunbrig | 20d |
| Takeda - Eohilia | 20d |
| Takeda - Oveporexton | 20d |
| TAKEDA | Psoriasis & Psoriatic Arthritis (Phase 3)| US | 20d |
| Trinity Life Sciences Exploration | 20d |
| UCB MG-Rare Patient Finder | 36d |
| VERTEX | AMKD | US | 20d |